openPR Logo
Press release

Regenerative Artificial Skin Market Growing Exponentially By 2026 Mylan N.V., Smith & Nephew, Mallinckrodt

01-02-2019 03:30 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Biotechnology

Regenerative Artificial Skin

Regenerative Artificial Skin

Artificial Skin Treatments

Various skin repair devices are available, which are used to heal the affected part. These include Dermagraft, OrCel, Integra, Biobrane, Apligraft, Matriderm, Hyalomatrix, Renoskin, and Composite Cultured Skin. Dermagraft is used to help in wound closure of diabetic foot ulcers. Orcel is used to cover and aid in wound healing. Composite Cultured Skin also contains living cells and is specifically used in children with recessive dystrophic epidermolysis bullosa. Integra is used for treatment of severe burns.

Download PDF Brochure of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-pdf/100

Incidence of accidental skin burns are increasing across the globe. Life threatening skin injuries, traumas, and burns require immediate surgical procedure to restore skin and avoid future complications. Skin burns are broadly classified into three levels, namely 1st, 2nd, and 3rd degree burns. In third degree of burns where there is little or no intact skin, artificial skin graft is the most useful treatment option. Artificial skin covers and protects the wound and also promotes regeneration of natural skin.

Artificial skin is usually prepared from collagen, which is easily resorbed by the body and facilitates generation of new skin on the affected area. According to the American Burn Association, 486,000 people received medical treatment for minor burns and 70,000 people were hospitalized for severe skin burn requiring acute care in the U.S, in 2015. Various players in the market are carrying R&D activities to develop new technology related to artificial skin regeneration. One such instance is an autologous spray on skin, Recell, by Avita Medical.

The market for regenerative artificial skin is growing in the U.S., mainly driven by increasing number of patients with skin diseases. According to Skin Cancer Foundation, each year over 5.4 million cases of non-melanoma skin cancer are reported and over 3.3 million people are treated for the same in the U.S. Also, there are more new cases of skin cancer reported than the combined incidence of cancers of the breast, prostate, lung, and colon each year. Regenerative artificial skin market in Europe is growing due to skin disease being a very pertinent issue in the region. Robust medical infrastructure, presence of global players, and advancements in technology also contribute to market growth of the regenerative artificial skin in the region. In Asia, the market for regenerative artificial skin is projected to grow in the near future due to increasing number of people opting for skin treatment procedures.

Regenerative Artificial Skin Market Taxonomy

The global regenerative artificial skin market is segmented on the basis of material type, end user and region.

On the basis of material type, the regenerative artificial skin market is segmented into temporary skin material, permanent skin material, and composite skin material.

Temporary skin material: Its effect lasts between several months and 2.5 years, depending on the type, quality, and quantity of injected material.

Permanent skin material: These are epidermal skin and dermal skin materials. Bio-Alcamid is a synthetic polymer that contains 97% water. It is injected into the inner tissue to fill and thicken it.

Composite Skin Material: These are further sub-segmented into skin graft and engineered skin material.

On the basis of end user, the global regenerative artificial skin market is segmented into hospitals, clinics, and burn care center. In hospitals, regenerative artificial skin technology is used in the treatment of deep skin wounds and also in plastic surgery. Healthcare providers use artificial skin to treat chronic wounds. Specialized burn care center extensively use artificial skin technology to treat burnt skin.

Request For Customization Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-customization/100

Rapid Advancements in Technology

Researchers and biotechnicians at the U.S army institute of surgical research are developing artificial skin that can be stored in a spray bottle and would regenerate and grow as applied on the body. This new technology would be of great aid in emergency situations, especially for military personnel during war situations. Furthermore, several companies in the market place are increasing their product portfolio related to regenerative artificial skin market. Some of the key players in the global regenerative artificial skin market are Integra Life Sciences Corporation, Mylan N.V., Johnson & Johnson Services, Inc. Smith & Nephew and Mallinckrodt plc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, 
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Regenerative Artificial Skin Market Growing Exponentially By 2026 Mylan N.V., Smith & Nephew, Mallinckrodt here

News-ID: 1466493 • Views:

More Releases from Coherent Market Insights - Biotechnology

Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 Period till 2027 | Medtronic Plc, Hill-Rom Holdings, iRhythm Technologies
Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 …
Coherent Market Insights published a report, titled,"Wearable Patch Market, by Technology (Connected and Regular), by Application (Monitoring, Drug Delivery, and Diagnostics), by End User (Healthcare and Fitness & Sports), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027." Wearable patches are used for monitoring and diagnosis of chronic diseases. Increasing prevalence of diseases such as atrial
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast Period 2017 - 2025 And The Top Competitors Are Crown Bioscience, ProSpec Tany TechnoGene, BPS Bioscience, Sigma Aldrich Company, Novoprotein Scientific
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast P …
Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players Biocon, Pfizer Inc., F. Hoffmann-La Roche Ltd, Amgen Inc., Kyowa Pharmaceutical Industry Co. Ltd, Boehringer Ingelheim GmbH, AstraZeneca, Novartis AG, and Merck & Co
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players …
Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., Bard1 Life Sciences Limited, Bio-Rad Laboratories, Abbott Laboratories, Becton, Dickinson and Company, Merck & Co., Inc., Qiagen N.V., and Thermo Fisher Scientific Inc
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., B …
The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies. Free Request Sample Copy

All 5 Releases


More Releases for Skin

Bellueur Skin Canada Review: Does Bellueur Skin Really Work?
Bellueur Skin Canada Only: https://rebrand.ly/01b756 Best Anti Aging Cream US Only: https://rebrand.ly/eee7f0 Are you feeling disappointed with your facial skin? Oh, not only you, many of us nowadays feel the same. Everybody wants healthy and bright skin. No one likes dull, wrinkled, and tainted skin. As we grow older our skin starts to lose firmness and gets wrinkled and dull. The Epidermis, the outermost layer of our skin keeps the moisture in
Juventus Skin Cream-Does Juventus Skin Cream Work-Complete Info
You Might Have asked why a Few Folks Juventus Skin Possess such Flawless and Flawless pores and skin. What exactly do they actually do and what things do they utilize to earn their skin glow shiny? During our teenagers, have to have skin that is exceptional. Whatever the instance, together with all of the age this is growing, it begins to decompose in a extraordinary way. Both tremendous desires are
Global Anti-Aging Facial Mask Sales Market For End Users/Applications - Oil Skin …
Researchmoz added Most up-to-date research on "Global Anti-Aging Facial Mask Sales Market For End Users/Applications - Oil Skin, Normal Skin, Dry Skin and Combination Skin" to its huge collection of research reports. In this report, the global Anti-Aging Facial Mask market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and
Australia Tissue Engineered - Skin Substitutes Market 2024: Biologic Skin Substi …
"The Latest Research Report Australia Tissue Engineered - Skin Substitutes Market Outlook to 2024 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Skin Substitutes Market GlobalDatas new report, Australia Tissue Engineered - Skin Substitutes Market Outlook to 2024, provides key market data on the Australia Tissue Engineered - Skin Substitutes market. The report provides value, in millions of US dollars, volume (in
Complicated Skin And Skin Structure Infections (cSSSI)-Pipeline Insights, 2017
Orbis Research delivers key insights on the global Complicated Skin And Skin Structure Infections (cSSSI) market in a new report titled “Complicated Skin And Skin Structure Infections (cSSSI)-Pipeline Insights, 2017” In this report, Orbis Research sheds light on the various factors and trends impacting market growth over the forecast period (2017 – 2022). “Complicated Skin And Skin Structure Infections (cSSSI)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs
Latest Report: Global Skin And Skin Structure Infections (SSSI) Market
Marketresearchreports.biz has added a new research report on the "Skin And Skin Structure Infections (SSSI)-API Insights, 2017" to its collection. The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API